Bio:cap 2026 brings together the global Life Science and AI ecosystem at the City Cube on the Berlin exhibition grounds. The event blends the focus of an investor conference with the energy of a festival: curated matchmaking, inspiring keynotes, deep-dive sessions, and interactive panels highlight innovations in biotech, diagnostics, and AI-driven health solutions. Networking is at the heart of bio:cap, with dedicated zones for founder-investor 1:1s, a Capital Zone for VCs and family offices, and informal lounge areas for spontaneous conversations. Attendees also experience Berlin’s unique vibe: move between idea-sparking installations, discover partner innovations at their booths, or grab snacks and drinks at a Berlin-style Späti.
Berlin’s dense network of leading universities, research institutions, and biotech startups provides the perfect environment for innovation and collaboration, making it an ideal host city for bio:cap. The event is shaped in close partnership with the Charité, BIH and HPI, supported by leading figures such as Prof. Heyo Kroemer (CEO, Charité), Prof. Eicke Latz (immunologist and life science investor), and Prof. Ariel Stern (HPI), a leading voice at the intersection of digital health, economics, and policy.
On the second evening, the official bio:cap Investival Party turns a hand-picked Berlin venue into a hub for vibrant discussions and new collaborations.
By combining strategic networking, cutting-edge science, and Berlin’s dynamic lifestyle, bio:cap showcases the future of Life Sciences and AI, making it a must-attend event for startups, investors, researchers, and policymakers worldwide.